Announced Wed, 22 Jul · 18:42 IST
Subsidiary Optival gets 3 drug license suspension orders in Karnataka
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹711.00
prior close
₹717.15
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-2.6-2.4-3.0+1.5+1.3————————
Up moveDown movePending
AI summary
MedPlus Health Services' subsidiary Optival Health Solutions received three drug license suspension orders from Karnataka drugs control authorities for three stores in Vijayapura and Chikkaballapura. Suspensions range from 1 to 2 days under Rule 65 of the Drugs and Cosmetics Act, 1940. Total potential revenue loss is just Rs 1.03 lacs across all three stores. Orders received on 21 July 2026.
Likely market impact
Negligible financial impact; routine regulatory compliance matter for a subsidiary with revenue loss of about Rs 1.03 lacs across 3 stores.